Turning fragile, manual handoffs into auditable, patient-centric orchestration across the cell and gene therapy lifecycle
Cell and gene therapies (CGTs) represent the forefront of personalized medicine. Each therapy is tailored to a single patient, manufactured and delivered within narrow time windows, and executed across a distributed ecosystem of hospitals, laboratories, manufacturers, logistics providers, and regulatory bodies.
While the clinical promise of CGTs is transformative, their operational reality is uniquely fragile. In this environment, coordination failures are not simply inefficiencies; they are patient-safety risks. Eliminating coordination risk has therefore become a critical requirement for organizations operating in the CGT space.
This blog explores why coordination risk is inherent in CGT supply chains and how SAP Cell and Gene Therapy Orchestration (CGTO), implemented by Novatio, addresses this challenge at its root.
Why is coordination risk inherent in cell and gene therapy?
Three characteristics distinguish CGT supply chains from traditional pharmaceutical operations:
Single patient production
CGTs are produced as a batch of one. There is no buffer, no alternate inventory, and no opportunity for rework if a process fails. A single breakdown can invalidate an entire therapy intended for one patient.
Extreme time sensitivity
Many CGTs operate within strict viability windows, from collection to infusion, oftenmeasured in hours rather than days. Delays at any point in the journey can render a therapy unusable and delay critical patient care.
Highly distributed execution
CGT workflows span multiple independent stakeholders, each operating their own systems and processes. Without unified orchestration, coordination depends heavily on manual communication, increasing the likelihood of misalignment and late intervention.
Together, these factors create a high-risk operational environment where even minor coordination failures can have significant clinical and regulatory consequences.
Where does coordination break down in practice?
In real-world CGT programs, coordination risk typically manifests in three areas:
1. Breaks in chain-of-identity and chain-of-custody (COI/COC)
Mislabeling, undocumented handoffs, or mismatches between patient identity and therapy material can compromise patient safety and regulatory compliance.
2. Lack of real-time visibility
When stakeholders lack a shared, real-time view of therapy status, location, or condition, issues are detected too late to intervene effectively.
3. Manual and disconnected workflows
Email-based coordination, spreadsheets, and paper documentation introduce transcription errors, inconsistent execution, and incomplete audit trails. These approaches do not scale with therapy volume or complexity.
These risks are structural, not procedural, and cannot be resolved through incremental process fixes alone.
How does SAP CGTO eliminate coordination risk?
SAP CGTO is a purpose built, to orchestrate patient-specific therapies across complex, time-critical supply chains. Rather than acting as another system of record, CGTO functions as a unifying orchestration layer that governs execution across stakeholders.
End-to-end traceability by design
SAP CGTO maintains a continuous, unbroken record of every action, transfer, and status change across the therapy lifecycle. Each order is tied directly to an individual patient, ensuring chain-of-identity and chain-of-custody are preserved from sample collection to infusion.
Real-time tracking and proactive alerts
By capturing location, status, and condition data in real time, CGTO enables early detection of delays, deviations, or environmental excursions. Alerts allow teams to act before issues escalate into therapy loss.
Intelligent task orchestration
CGTO replaces manual coordination with system-driven task assignments and sequencing. Dependencies, notifications, and exception handling are automated, significantly reducing reliance on human intervention and minimizing error.
Built-in regulatory and audit readiness
Compliance is embedded into daily operations through immutable audit trails, role-based access controls, secure data handling, and label integration. Documentation is generated as part of execution, not assembled retrospectively for inspections.
Unified integration across the CGT ecosystem
CGTO integrates tightly with manufacturing execution systems (MES), enterprise resource planning (ERP), and logistics providers. This closes operational loops between scheduling, production, transport, and administration, eliminating blind spots across the therapy journey.
What organizations gain from eliminating coordination risk?
Organizations that move from manual coordination to orchestrated execution experience tangible operational benefits:
- Greater execution reliability across patient-specific workflows
- Reduced therapy loss caused by delays or misalignment
- Faster response to exceptions through real-time visibility
- Consistent audit readiness across global regulatory environments
- Improved confidence when scaling from clinical trials to commercial operations
Most importantly, these improvements directly support patient safety and trust—critical outcomes in personalized medicine.
How Novatio Can Help?
Successfully eliminating coordination risk requires more than technology deployment. Organizations should focus on:
- Defining patient-centric order and data models
- Ensuring tight integration with MES, ERP, and logistics systems
- Establishing clear governance and role-based accountability
- Training stakeholders to operate within orchestrated workflows
- Piloting high-risk pathways before scaling broadly
Novatio’s implementation approach combines domain expertise, proven accelerators, and structured governance to help organizations realize these outcomes efficiently and sustainably.
Conclusion: from coordination risk to patient confidence
In cell and gene therapy, coordination risk is unavoidable, but it is not unmanageable.
By replacing fragmented systems and manual handoffs with patient-centric orchestration, SAP CGTO enables organizations to move from reactive execution to controlled, compliant, and predictable operations.
Implemented with Novatio’s life sciences expertise, SAP CGTO transforms coordination from a source of risk into a foundation for patient confidence – ensuring every therapy journey is executed with precision, visibility, and trust.
Watch the Webinar
From Chain-of-Custody to Patient Confidence with SAP CGTO 5 March 2026- Watch The Webinar
